196 related articles for article (PubMed ID: 24752964)
1. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J
Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964
[TBL] [Abstract][Full Text] [Related]
2. Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.
Shi X; Peng Y; Du X; Liu H; Klocker H; Lin Q; Shi J; Zhang J
Prostate; 2017 Oct; 77(14):1424-1437. PubMed ID: 28850686
[TBL] [Abstract][Full Text] [Related]
3. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
[TBL] [Abstract][Full Text] [Related]
4. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
[TBL] [Abstract][Full Text] [Related]
5. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia.
Alonso-Magdalena P; Brössner C; Reiner A; Cheng G; Sugiyama N; Warner M; Gustafsson JA
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2859-63. PubMed ID: 19196965
[TBL] [Abstract][Full Text] [Related]
6. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
7. Integrating spatial transcriptomics and single-cell RNA-sequencing reveals the alterations in epithelial cells during nodular formation in benign prostatic hyperplasia.
Fei X; Liu J; Xu J; Jing H; Cai Z; Yan J; Wu Z; Li H; Wang Z; Shen Y
J Transl Med; 2024 Apr; 22(1):380. PubMed ID: 38654277
[TBL] [Abstract][Full Text] [Related]
8. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
Zhou J; Lei Y; Chen J; Zhou X
Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
[TBL] [Abstract][Full Text] [Related]
9. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.
Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X
Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788
[TBL] [Abstract][Full Text] [Related]
10. Modulatory effect of aquaporin 5 on estrogen-induced epithelial-mesenchymal transition in prostate epithelial cells.
Fan Y; Song TR; Wei Q; Yang L; Lin T; Feng XB; Wang XD; Huang ZL; Feng SJ
Chin Med J (Engl); 2020 Oct; 134(4):448-455. PubMed ID: 33031138
[TBL] [Abstract][Full Text] [Related]
11. MIR663AHG as a competitive endogenous RNA regulating TGF-β-induced epithelial proliferation and epithelial-mesenchymal transition in benign prostate hyperplasia.
Tong S; Mo M; Hu X; Wu L; Chen M; Zhao C
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23391. PubMed ID: 37518988
[TBL] [Abstract][Full Text] [Related]
12. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown.
Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464
[TBL] [Abstract][Full Text] [Related]
13. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.
Wu X; Gu Y; Li L
Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977
[TBL] [Abstract][Full Text] [Related]
14. The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition.
Chen J; Rong N; Liu M; Xu C; Xiong Q; Lei Y
Toxicol Appl Pharmacol; 2021 Jan; 411():115384. PubMed ID: 33359661
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia.
Schulze H; Barrack ER
Prostate; 1987; 11(2):145-62. PubMed ID: 2444954
[TBL] [Abstract][Full Text] [Related]
16. Evidence of TGF-β1 mediated epithelial-mesenchymal transition in immortalized benign prostatic hyperplasia cells.
Hu S; Yu W; Lv TJ; Chang CS; Li X; Jin J
Mol Membr Biol; 2014; 31(2-3):103-10. PubMed ID: 24650126
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.
Song L; Shen W; Zhang H; Wang Q; Wang Y; Zhou Z
Bosn J Basic Med Sci; 2016 Jul; 16(3):201-8. PubMed ID: 27294569
[TBL] [Abstract][Full Text] [Related]
18. LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia.
He Y; Ou Z; Chen X; Zu X; Liu L; Li Y; Cao Z; Chen M; Chen Z; Chen H; Qi L; Wang L
Sci Rep; 2016 May; 6():27051. PubMed ID: 27243216
[TBL] [Abstract][Full Text] [Related]
19. GV1001 interacts with androgen receptor to inhibit prostate cell proliferation in benign prostatic hyperplasia by regulating expression of molecules related to epithelial-mesenchymal transition.
Kim Y; Lee D; Jo H; Go C; Yang J; Kang D; Kang JS
Aging (Albany NY); 2021 Feb; 13(3):3202-3217. PubMed ID: 33539321
[TBL] [Abstract][Full Text] [Related]
20. Expression of β-catenin and mesenchymal markers in canine prostatic hyperplasia and carcinoma.
Lean FZ; Kontos S; Palmieri C
J Comp Pathol; 2014 May; 150(4):373-81. PubMed ID: 24529514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
